Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.115 USD | +2.29% | -3.04% | +28.90% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.90% | 128M | |
+5.25% | 109B | |
+11.20% | 105B | |
-0.38% | 22.25B | |
-12.04% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.05% | 16.85B | |
+3.12% | 13.76B | |
+36.62% | 12.46B |
- Stock Market
- Equities
- KPTI Stock
- News Karyopharm Therapeutics Inc.
- RBC Cuts Price Target on Karyopharm Therapeutics to $7 From $9, Maintains Outperform Rating